0
Buy Lagosa online

Lagosa 100 caps (150mg)

Therapeutic indications Logosa is indicated as adjuvant hepatoprotection treatment in: - toxic substances exposure cases with a high risk of hepatotoxicity. - chronic hepatitis and cirrhotic The normal doses recommended to use is 300 mg of silymarin two pills of Lagosa per day. The pills will be administrated with a little dose of water.more
35.00$
add to cart Out of stock Notify me
caracteristics
description

Therapeutic indications
Logosa is indicated as adjuvant hepatoprotection treatment in:
- toxic substances exposure cases with a high risk of hepatotoxicity.
- chronic hepatitis and cirrhotic
The normal doses recommended to use is 300 mg of silymarin two pills of Lagosa per day.
The pills will be administrated with a little dose of water.
One pill contains silymarin 150 mg in the form of dry methanolic extract of milk thistle fruit 240 mg and excipients: nucleus- lactose, cellulose, microcrystalline, colloidal silicon dioxide, croscarmellose sodium type A, povidone K30, talc, magnesium stearate, solid fat; dragee layer: shellac, sugar, calcium carbonate, talc, gum arabic, corn starch, titanium dioxide (E171), colloidal silicon dioxide, povidone K30, macrogol 6000, 85% glycerol, polysorbate 80 wax mountain glycol
In case, you have hypersensitivity at the products compounds it is not indicated to use this medicine.
Since this product contains lactose, patients with hereditary problems of galactose intolerance, lactase deficiency (Lapp) malabsorption or glucose-galactose malabsorption should not take this medicine.
Since this product contains sucrose, patients with rare hereditary problems of fructose intolerance, glucose malabsorption, galactose or sucrose-isomaltase insufficiency should not take this medicine.
Very rare can appear allergic reactions , Occasionally can be observed a laxative effect and gastralgia.
Studies on animals have shown that this medicine has not toxic effect. It's administration while pregnancy and breastfeeding need caution after the doctor evaluation of the benefit maternal / fetal risk potential.

review
no reviews